33rd Annual CFS™ Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 23.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


CONTINUING EDUCATION CREDIT (Pharmacists, Nurses, Nurse Practitioners, and Physician Assistants):
You will receive a certificate of attendance for the CME-certified sessions (those designated for AMA/PRA Category 1 Credits™) which may be submitted to state licensing boards for determination of credit reciprocity (conversion to CEUs).

Acknowledgment of Commercial Support

This activity is supported by educational grants from Astellas, AstraZeneca, Boston Biomedical Pharma, Inc., Celgene Corporation, Clovis Oncology, Eisai Inc., Exelixis, Incyte Corporation, Ipsen Biopharmaceuticals, Inc., Lilly, Merck & Co., Inc., Merrimack Pharmaceuticals, Nektar Therapeutics, Novartis Pharmaceuticals Corporation, Novocure, Pharmacyclics, Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Puma Biotechnology, Taiho Oncology, Inc., and Takeda Oncology.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

The CFS™ Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® is wholly owned and operated by PER Events, LLC, an affiliate of Physicians' Education Resource®.
33rd Annual CFS™ Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®


Program Co-Chairs

Edward Ambinder, MD
Clinical Professor
Medicine, Hematology and Medical Oncology
Clinical Professor, Oncological Sciences
Mount Sinai Hospital
New York, NY


Franco Muggia, MD
Professor, Department of Medicine
NYU Langone Medical Center
New York, NY




Steering Committee

Kimberly L. Blackwell, MD
Medical Oncologist
Duke Cancer Center
Durham, NC




C. Ola Landgren, MD, PhD
Hematologic Oncologist
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY



Jason J. Luke, MD
Medical Oncologist
Assistant Professor of Medicine
University of Chicago Medicine
Chicago, IL



John L. Marshall, MD
Chief, Division of Hematology/Oncology
Georgetown University Hospital
Associate Director, Clinical Research
Lombardi Comprehensive Cancer Center
Washington, DC


William K. Oh, MD
Chief, Division of Hematology and Medical Oncology
Professor of Medicine and Urology
Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics
Icahn School of Medicine at Mount Sinai
Associate Director, Clinical Research
The Tisch Cancer Institute
New York, NY


Naiyer Rizvi, MD
Director, Thoracic Oncology
Director, Immunotherapeutics
Price Chair, Clinical Translational Research
Columbia University Medical Center
New York, NY

 

Faculty

Ghassan K. Abou-Alfa, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY




Sylvia Adams, MD
Medical Oncologist
Associate Professor, Department of Medicine
NYU Langone Medical Center
New York, NY



Emmanuel S. Antonarakis, MB BCh
Associate Professor of Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD




Maria E. Arcila, MD
Pathologist
Acting Director, Diagnostic Molecular Pathology Laboratory
Memorial Sloan Kettering Cancer Center
New York, NY



Farrukh Awan, MBBS
Department of Internal Medicine
Division of Hematology
The James Cancer Hospital and Solove Research Institute
Columbus, OH



Chandra Belani, MD
Miriam Becker Professor of Medicine
Penn State Hershey College of Medicine
Deputy Director, Penn State Cancer Institute
Hershey, PA



Michael J. Birrer, MD, PhD
Professor
Harvard Medical School
Director, Gynecologic Medical Oncology
Leader, DF/HCC Gynecologic Cancers Program
Massachusetts General Hospital
Boston, MA


Patrick I. Borgen, MD
Chairman, Department of Surgery
Maimonides Hospital
Director, Brooklyn Breast Cancer Program
Brooklyn, NY



Renier J. Brentjens, MD, PhD
Medical Oncologist
Director, Cellular Therapeutics
Memorial Sloan Kettering Cancer Center
New York, NY



Joshua Brody, MD
Director, Lymphoma Immunotherapy Program
Icahn School of Medicine at Mount Sinai
Hess Center for Science and Medicine
New York, NY



Marcia S. Brose, MD, PhD
Associate Professor of Otorhinolaryngology
Head and Neck Surgery
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA


Barbara Burtness, MD
Clinical Research Program Leader, Head and Neck Cancers Program
Co-Director, Developmental Therapeutics Research Program
Professor of Medicine, Medical Oncology
Yale Cancer Center
New Haven, CT


Howard "Skip" Burris III, MD
Chief Medical Officer
Executive Director, Drug Development Program
Sarah Cannon Research Institute
Nashville, TN



Jennifer Ang Chan, MD, MPH
Clinical Director
Program in Carcinoid and Neuroendocrine Tumors
Senior Physician
Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Boston, MA



Deirdre Cohen, MD
Assistant Professor of Medicine
Division of GI Oncology
Laura and Isaac Perlmutter Cancer Center
NYU Langone Medical Center
New York, NY




Cathy Eng, MD
Professor
Department of Gastrointestinal (GI) Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX




Francisco J. Esteva, MD, PhD
Professor of Medicine
Director, Breast Medical Oncology
Associate Director, Clinical Investigation
Laura and Isaac Perlmutter Cancer Center
NYU Langone Medical Center
New York, NY



Anna C. Ferrari, MD
Professor of Medicine
Director, Genitourinary Cancer Program
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ



Edward Garon, MD
Hematology & Oncology
Ronald Reagan UCLA Medical Center
UCLA Medical Center
Santa Monica, CA



David M. Gershenson, MD
Professor
Department of Gynecologic Oncology & Reproductive Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX



Andre Goy, MD, MS
Chairman and Director
Lymphoma Division Chief
John Theurer Cancer Center at Hackensack UMC
Hackensack, NJ
Chief Science Officer and Director of Research and Innovation of RCCA (New Jersey)
Professor of Medicine, Georgetown University
Washington, DC



Missak Haigentz, Jr, MD
Associate Professor of Clinical Medicine
Albert Einstein College of Medicine/
Montefiore Medical Center
Bronx, NY



Omid Hamid, MD
Chief, Translational Research and Immunotherapy
Director, Melanoma Therapeutics
The Angeles Clinic and Research Institute
Los Angeles, CA



Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief, Medical Oncology
Associate Director, Translational Research
Yale Cancer Center
Yale School of Medicine
New Haven, CT


Thomas Herzog, MD
Clinical Director
University of Cincinnati Cancer Institute
Professor of Obstetrics and Gynecology
UC College of Medicine
Cincinnati, OH


Howard S. Hochster, MD
Professor of Medicine (Medical Oncology)
Associate Director for Clinical Sciences
Yale Cancer Center
Clinical Program Leader, Gastrointestinal Cancers Program
Smilow Cancer Hospital
Clinical Research Program Leader, Gastrointestinal Cancers Program Yale Cancer Center
New Haven, CT


Jimmie C. Holland, MD
Psychiatrist
Wayne E. Chapman Chair in Psychiatric Oncology
Memorial Sloan Kettering Cancer Center
New York, NY



Sundar Jagannath, MD
Director, Multiple Myeloma Program
Professor of Medicine (Hematology and Medical Oncology)
The Tisch Cancer Institute
Mount Sinai Medical Center
New York, NY


Mohammad Jahanzeb, MD, FACP
Professor of Clinical Medicine
Division of Hematology/Oncology
Medical Director, Sylvester Comprehensive Cancer Center
at Deerfield Beach
Associate Director, Community Outreach
University of Miami Health System
Miami, FL


Mark G. Kris, MD
Attending Physician, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY



Mario E. Lacouture, MD
Director, Oncodermatology Program
Memorial Sloan Kettering Cancer Center
New York, NY




Zachary Landman, MD
Senior Institute Associate
Institute for Strategy & Competitiveness at Harvard Business School
Boston, MA




Corey J. Langer, MD, FACP
Professor of Medicine
Hematology/Oncology Division
University of Pennsylvania
Director, Thoracic Oncology
Abramson Comprehensive Cancer Center
Philadelphia, PA


Dung Thi Le, MD
Assistant Professor of Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD




Benjamin P. Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program
Mount Sinai Health System
Associate Director, Cancer Clinical Trials Office
Mount Sinai Hospital
New York, NY


Sagar Lonial, MD
Professor
Emory School of Medicine
Executive Vice Chair
Department of Hematology & Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA


Thomas J. Lynch, Jr, MD
Chairman and Chief Executive Officer
Massachusetts General Physicians Organization
Boston, MA




Maurie Markman, MD
Medical Oncologist
President, Medicine and Science
Eastern Regional Medical Center
Philadelphia, PA



Michael J. Mauro, MD
Hematologist
Leader, Myeloproliferative Neoplasms Program
Memorial Sloan Kettering Cancer Center
New York, NY



Ruben A. Mesa, MD, FACP
Professor of Medicine
Chair, Division of Hematology & Medical Oncology
Deputy Director, Mayo Clinic Cancer Center
Scottsdale, AZ



Michael J. Morris, MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY




Craig H. Moskowitz, MD
Clinical Director, Division of Hematologic Oncology
Steven A. Greenberg Chair
Memorial Sloan Kettering Cancer Center
New York, NY



Jonathan Moss, MD, PhD
Professor, Department of Anesthesia and Critical Care
The University of Chicago Medicine
Chicago, IL




Susan M. O'Brien, MD
Associate Director, Clinical Science,
Chao Family Comprehensive Cancer Center
Medical Director
Sue and Ralph Stern Center for Cancer Clinical Trials and Research
UC Irvine Health
Orange, CA


Anna C. Pavlick, DO
Medical Oncologist
Solid Tumors, Oncology
NYU Langone Medical Center
New York, NY



Roman Perez-Soler, MD
Guttman Professor of Medicine
Professor of Medicine and Molecular Pharmacology
Chairman, Department of Oncology
Chief, Division of Medical Oncology
Deputy Director, Albert Einstein Cancer Center
New York, NY


Daniel P. Petrylak, MD
Professor of Medicine, Medical Oncology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT


Tony Philip, MD FACP
Assistant Professor of Medicine
Division of Hematology/Oncology
Hofstra North Shore – LIJ School of Medicine
Lake Success, NY



Malcolm Pike, PhD
Attending Epidemiologist
Memorial Sloan Kettering Cancer Center
New York, NY

Suresh S. Ramalingam, MD
Professor, Chief of Thoracic Oncology
Director of Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, GA




David Reardon, MD
Clinical Director, Center for Neuro-Oncology
Physician, Dana-Farber Cancer Institute
Boston, MA

Gregory Riely, MD, PhD
Vice Chair, Clinical Trials Office
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY



Ellen K. Ritchie, MD
Assistant Professor of Medicine
Member, Leukemia Program
Weill Cornell Medical College, Cornell University
Associate Attending Physician, NewYork-Presbyterian Hospital
New York, NY


Gail J. Roboz, MD
Department of Hematology
Associate Professor of Medicine
Weill Cornell Medical College, Cornell University
Associate Attending Physician, NewYork-Presbyterian Hospital
New York, NY


Mark Robson, MD
Medical Oncologist
Clinic Director, Clinical Genetics Service
Memorial Sloan Kettering Cancer Center
New York, NY



Tamar Safra, MD
Medical Oncologist
Head of OncoGynecological Unit
Department of Oncology
Tel Aviv Sourasky Medical Center
Sackler Medical School
Tel Aviv University
Tel Aviv, Israel


Leonard Saltz, MD
Medical Oncologist
Chief, Gastrointestinal Oncology Service
Head, Colorectal Oncology Section
Memorial Sloan Kettering Cancer Center
New York, NY


Oliver Sartor, MD
Medical DirectorAssociate Director, Clinical Programs
Tulane Cancer Center
C.E. and Bernadine Laborde Professor of Cancer Research
Professor, Department of Medicine: Section of Hematology & Medical Oncology and Department of Urology
New Orleans, LA



Mark A. Socinski, MD
Professor of Medicine and Thoracic Surgery
Director, Lung Cancer Section, Division of Hematology/Oncology
Clinical Associate Director, Lung SPORE
Co-Director, UPMC Lung Cancer Center of Excellence
Co-Leader, Lung Cancer Program
University of Pittsburgh
Pittsburgh, PA

David B. Solit, MD
Medical Oncologist
Geoffrey Beene Chair
Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center
New York, NY


Martin S. Tallman, MD
Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY




Eleanora Teplinsky, MD
Assistant Professor
North Shore-LIJ School of Medicine
New Hyde Park, NY




Jonathan C. Trent, MD, PhD
Professor of Medicine
Co-Director, Musculoskeletal Center
Sarcoma Medical Research Program
Sylvester Comprehensive Cancer Center
University of Miami Health System
Miami, FL

Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX



Srdan Verstovsek, MD, PhD
Professor of Medicine
Director, Hanns A. Pielenz Clinical Research Center
for Myeloproliferative Neoplasms
Department of Leukemia
University of Texas MD Anderson Cancer Center
Houston, TX


Heather A. Wakelee, MD
Associate Professor, Medicine (Oncology)
Stanford University Medical Center
Stanford, CA




Jeremy Warner, MD, MS
Assistant Professor of Medicine and Biomedical Informatics
Vanderbilt University Medical Center
Nashville, TN




Samuel Waxman, MD
Distinguished Service Professor
Icahn School of Medicine at Mount Sinai
Founder and CEO
Samuel Waxman Cancer Research Foundation
Honorary Professor, Shanghai Jiao Tong University
New York, NY


Jeffrey S. Weber, MD, PhD
Senior Member and Director
Donald A. Adam Comprehensive Melanoma Research Center
Moffitt Cancer Center
Tampa, FL



Colin D. Weekes, MD, PhD
Associate Professor
Division of Medical Oncology
University of Colorado School of Medicine
University of Colorado Hospital
Aurora, CO


William C. Wierda, MD, PhD
Professor, Department of Leukemia, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX




Georgia L. Wiesner, MD, MS
Director, Clinical and Translational Hereditary Cancer Program
Ingram Professor of Cancer Research
Professor of Medicine
Cancer Geneticist
Vanderbilt-Ingram Cancer Center
Nashville, TN


Jedd D. Wolchok, MD, PhD
Medical Oncologist
Chief, Melanoma and Immunotherapeutics Service
Lloyd J. Old Chair for Clinical Investigation
Memorial Sloan Kettering Cancer Center
New York, NY


Norman Wolmark, MD
Professor of Surgery
Temple University School of Medicine
Chairman, NSABP
Philadelphia, PA



Jennifer Wu, MD
Solid Tumors, Leukemia & Lymphoma, Hematology, Oncology
NYU Langone Medical Center
Assistant Professor, Department of Medicine
Perlmutter Cancer Center
New York, NY


Anas Younes, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, NY




Rex Yung, MD, FCCP
Pulmonary Medicine
Pulmonary Intensivist, Critical Care Team
Greater Baltimore Medical Center
Baltimore, MD




Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By